Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

BACKGROUND: The novel coronavirus disease (2019-nCoV) has been affecting global health since the end of 2019 and there is no sign that the epidemic is abating . The major issue for controlling the infectious is lacking efficient prevention and therapeutic approaches. Chloroquine (CQ) and Hydroxychlo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Nan, Han, Shengli, Liu, Rui, Meng, Liesu, He, Huaizhen, Zhang, Yongjing, Wang, Cheng, Lv, Yanni, Wang, Jue, Li, Xiaowei, Ding, Yuanyuan, Fu, Jia, Hou, Yajing, Lu, Wen, Ma, Weina, Zhan, Yingzhuan, Dai, Bingling, Zhang, Jie, Pan, Xiaoyan, Hu, Shiling, Gao, Jiapan, Jia, Qianqian, Zhang, Liyang, Ge, Shuai, Wang, Saisai, Liang, Peida, Hu, Tian, Lu, Jiayu, Wang, Xiangjun, Zhou, Huaxin, Ta, Wenjing, Wang, Yuejin, Lu, Shemin, He, Langchong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467095/
https://www.ncbi.nlm.nih.gov/pubmed/32920291
http://dx.doi.org/10.1016/j.phymed.2020.153333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467095/
https://www.ncbi.nlm.nih.gov/pubmed/32920291
http://dx.doi.org/10.1016/j.phymed.2020.153333

Ejemplares similares